Pacylex Pharmaceuticals develops a precision medicine solution for multiple common cancers.
Pacylex has raised $1.4M in total funding. The most recent round was Grant. The last funding was announced in October 2022.
Pacylex's investors include U.S. Department of War, VA Angels, Greenfire Bio.
Pacylex is headquartered in Edmonton, Canada.
Pacylex Pharmaceuticals develops a precision medicine solution for multiple common cancers.
Pacylex is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Pacylex — Funding & Investors." VCBacked, October 11, 2022, https://www.vcbacked.co/company/pacylex. Accessed September 29, 2026.
VCBacked. (2022). Pacylex — Funding & Investors. Retrieved September 29, 2026, from https://www.vcbacked.co/company/pacylex
{{cite web |title=Pacylex — Funding & Investors |url=https://www.vcbacked.co/company/pacylex |website=VCBacked |access-date=September 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated